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Abstract
Mycobacterium avium complex (MAC) and Mycobacterium avium paratuberculosis (MAP)
cause zoonotic infections transmitted by birds and livestock herds. These pathogens have
remained as serious economic and health threats in most areas of the world. As zoonotic
diseases, the risk of development of occupational disease and even death outcome
necessitate implementation of control strategies to prevent its spread. Zoonotic MAP
infections include Crohn’s disease, inflammatory bowel disease, ulcerative colitis,
sarcoidosis, diabetes mellitus, and immune‐related diseases (such as Hashimoto’s
thyroiditis). Paratuberculosis has classified as type B epidemic zoonotic disease according
to world health organization which is transmitted to human through consumption of
dairy and meat products. In addition, MAC causes pulmonary manifestations and
lymphadenitis in normal hosts and human immunodeficiency virus (HIV) progression (by
serotypes 1, 4, and 8). Furthermore, other subspecies have caused respiratory abscesses,
neck lymph nodes, and disseminated osteomyelitis in children and ulcers. However, the
data over the occupational relatedness of these subspecies is rare. These agents can
cause occupational infections in susceptible herd breeders. Several molecular methods
have been recognized as proper strategies for tracking the infection. In this study, some
zoonotic aspects, worldwide prevalence and control strategies regarding infections due
to MAP and MAC and related subspecies has been reviewed.
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1 | CONTEXT
The species of Mycobacterium avium has been classified into four
subspecies including M. avium, M. hominissuis, M. silvaticum, and M.
paratuberculosis with a high degree of genetic similarity, but various
degrees of infectivity in host species. M. avium subsp. paratuberculosis
(MAP) species is one of the critical pathogens in the livestock
industry, a secret threat and a problem in the world’s milk herds
(Hamilton, Weir, & Haas, 2017b). Recently it has been critically
considered due to its tracking in Crohn’s disease (CD) in human and
millions of dollars of economic losses and trade restrictions on the
livestock industry in many countries (Jarand, Davis, Cowie, Field, &
Fisher, 2016).
Paratuberculosis in animals, also known as Jones disease is a
chronic, infectious, and often fatal colon granulomatous infection
(Eslami, 2011). That was first identified in cattle and subsequently in
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sheep and goats (Grant, 2005). Paratuberculosis bacilli can be colonized
in most animals including, domestic or wild ruminants, wild carnivores,
laboratory animals, and nonhuman primates (Waddell et al., 2008).
M. avium, belonging to the slow‐growing group of mycobacteria,
causes zoonotic disease which develops in humans. Among the
opportunistic pathogens, the term M. avium, M. intracellulare, and M.
scrofulaceum (MAIS) was previously referred to as a group of slow‐
growing mycobacteria, seeming very similar in appearance and in
some cases, thus difficult to be subtracted from each other (Tortoli,
2012). Recently, the term MAIS have not been used according to the
results of techniques such as nucleic acid hybridization, antigenic
analysis, and the ability of the organism to metabolize urea, in
which M. scrofulaceum is easily distinguishable from M. avium and
M. intercellular. The word “MAC” stands for the M. avium complex
that contains the two main species M. avium and M. intracellulare
and several other subspecies in this complex (M. chimaera and
M. lepraemurium) also isolated from human and considered as
zoonotic agents (Hamilton et al., 2017b; Jarand et al., 2016)
2 | INFECTION OF M. AVIUM SUBSP.
PARATUBERCULOSIS IN HUMANS
The pathogenicity of paratuberculosis in humans depends on age,
genetics, environmental contamination, health status, geographical
location, dietary habits, the presence of specific microorganisms,
mechanisms of disease, medication, and host immune responses. The
two major clinical manifestations of paratuberculosis in human
include inflammatory bowel disease (IBD) and autoimmune diseases
(asthma, insulin‐dependent diabetes mellitus, sarcoidosis, rheumatoid
arthritis, multiple sclerosis, and celiac disease (Grant, 2005; Naser,
Sagramsingh, Naser, & Thanigachalam, 2014). A group of chronic
gastrointestinal disorders with unspecified agents are classified into
three groups including ulcerative colitis, CD, and IBD based on
clinical findings (Pierce, 2018).
3 | CROHN ’S DISEASE
Dolseil in 1913, identified a similar pathology between the intestinal
tissue of patients with intestinal tuberculosis CD in men and
paratuberculosis in ruminants (Jones disease), demonstrating a
relationship between the bacilli and CD several years later (Alcedo,
Thanigachalam, & Naser, 2016). Findings highlight the disease by
observation of lack of similarity between isolates from cows and
those from human populations and no maternal/vertical transmission
of Mycobacterium avium paratuberculosis. It seems that the suscept-
ibility rate to the bacterium is not the same in various regions among
populations. CD affects 1–2 million people worldwide (Atreya et al.,
2014). It is currently believed that CD is a polygenic disease in which
MAP is one of the causative agents along with other agents such as
pathogens (bacteria, viruses, and fungi), environmental factors and
inappropriate immune response in genetically susceptible hosts
(McNees, Markesich, Zayyani, & Graham, 2015). CD as a systemic
illness has been identified with the initial symptoms of chronic otitis
media that may occur in the mouth from the gastrointestinal tract in
any area. CD pathogenicity mechanism is similar to ulcerative colitis.
However, due to inadequate inactivation of intestinal protease and
an excess of glycosidases, degradation of the mucosal layer leads to
damage to the intestinal duct. The formation of inflammatory
granulomatosis is a result of increased lumen penetration of the
entire intestine into antigens and accumulation of macrophages. The
disease begins with symptoms of abdominal pain, diarrhea, lethargy
and weight, night sweats, vomiting, skin rash, microcytic anemia, oral
ulcer, and arthralgia, and in some cases peritonitis, appendicitis, and
perforation of the ulcerative ileum. CD is a progressive and
unbreakable disease that occurs throughout the world (especially in
industrialized countries; Baumgart & Sandborn, 2012).
Based on studies, there is evidence that the etiology of the CD (in
humans) and Jones disease (in the animal) have been confirmed, which
include bacterial survival in commercial pasteurization methods, MAP
detection in the tissues and blood of contaminated patients, increased
antibody levels in sera samples of patients in the face of bacterial
antigens, bacterial tracing in infected mothers, NOD2/CARD15 muta-
tions, and response to antibiotic therapy by the macrolide family (Davis
& Park, 2018; Kuenstner et al., 2017). On the other hand, there is a lack
of similarities between the genotypes of bovine and human isolates, the
isolation of bacteria from individuals without CD, the lack of sufficient
evidence to confirm the consumption of contaminated food by patients,
and the lack of transmission of bacteria from the infected mother and
inactivation of bacteria causing the CD which highlight the agent
existence (Mendoza, Lana, & Díaz‐Rubio, 2009). The transmission of
paratuberculosis through a food chain or contaminated water resources,
especially pasteurized milk, and unheated meat to humans, has caused
animals as reservoirs to play an important role in the possible
transmission of disease to humans. The difference in the prevalence
of CD is seen in countries (Europe and the United States) and even in
different ethnic groups, with about 170 and 40 per 100,000 children
and adults in the North America and Europe, respectively. Although
in Canada, Europe, and the United States the disease is often diagnosed
in women, there is no evidence of its association with specific sex (Dirac
et al., 2012; Mendoza et al., 2009; Shafiei, 2018 #303).
Based on clinical findings and diagnostic techniques, CD is
associated with ulcerative colitis in humans and Jones disease in
primates, but there are also exceptions including the main problem
with paratuberculosis is the infection of the gastrointestinal tract at
any time and bacterial survival for 2–10 years without causing
obvious symptoms of infection in the animal. On the other hand,
during the subclinical phase, the intermittent excretion of bacteria
through milk and stool is considered as a major source for
transferring bacilli among the herds (Hermon‐Taylor et al., 2000b).
As the main route of transmission, gastrointestinal or fecal–oral
transmission is mainly contaminated by oral ingestion of water or
food contaminated with the feces of adult infected animals. Other
ways of spreading the disease between the herd and human
populations are the respiratory transmission following inhalation of
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dust caused by inert material (pasture or fertilizer) and the transient
transmission through the semen and sperm fluid of the male livestock
contaminated with the sensitive members of the herd. Evidence
suggests that vertical transmission through intrauterine and endo-
crine glands (milk, colostrum) is also referred to as other routes
(Keating, Daly, & Practice, 2013). Paratuberculosis is prevalent in
cattle, occurring in four stages: latent, subclinical, clinical, and
advanced, which in the advanced phase, the quick death of the
animal will be the outcome.M. avium subsp. avium causes three major
clinical features in humans including pulmonary disease and
lymphadenitis in healthy subjects and disseminated disease in human
immunodeficiency virus (HIV)‐infected patients (Hamilton, Ahmed,
Toze, & Haas, 2017a; Maekawa et al., 2011). Furthermore, these
agents caused infection following patient’ organs transplantation
(Chiers et al., 2012). The causative agent was identified as an
occupational infectious bacterium in roof‐harvested rainwater in
Queensland, Australia (Lara et al., 2011). In addition, high soil
exposure (≥2/weeks), determined as a significant risk factor (Yong,
Choi, Lee, Whang, & Shin, 2011). It has been also reported in birds,
pig’s wild boars, elephants, horse (M. silvaticum), and dog (M.
hominissuis; Escobar‐Escamilla et al., 2014; Nunes‐Costa, Alarico,
Dalcolmo, Correia‐Neves, & Empadinhas, 2016; Yong et al., 2011).
Therefore, there is the possibility of incidence of zoonotic and
occupational infections by these subspecies.
4 | OTHER MAC SUBSPECIES
Other subspecies of MAC based on 16s rRNA sequencing mostly
include M. chimaera (or MAC‐A serovar from human respiratory
system), M. colombiense (from children lymph nodes), M. arosiense (or
MAC‐X serovar from systemic osteomyelitis of HIV‐infected chil-
dren), M. indicus pranii (MIP or Mw), M. vulneris (isolated from ulcers),
M. xenopi, and M. lepraemurium which caused infections less common
in humans. Because of nonoptimization of diagnostic methods, these
subspecies are underestimated (Biet & Boschiroli, 2014; Lamont,
Bannantine, Armién, Ariyakumar, & Sreevatsan, 2012; Rosenfeld &
Bressler, 2010). They are mostly isolated from sputum and other
pulmonary specimens. It is generally believed that vast environ-
mental sources such as swimming pools, tap waters, potting, and
aquaria act as infectious niche.
5 | EPIDEMIOLOGY OF MAP AND MAC
MAC mainly causes the infection in pigs and poultry. Other hosts
include cows, sheep, goats, deer, and antelopes, bagpipes, primates,
and horses which can transfer the infection to humans. M. avium,
which is also widely isolated from the environment, such as water,
soil, air, and unpasteurized milk can be as a primary source for
bacterial spread (Grant, 2005; Waddell et al., 2008). The differentia-
tion between avium and intracellulare subspecies is difficult by
phenotypic methods and necessitates techniques that are usually
only available in reference laboratories, and therefore, these species
are often reported as MAC (Norton, Johnson, Jones, & Heuer, 2010).
In humans, MAC is one of the opportunistic pathogens causing
swollen neck lymph nodes or scrofula (especially in children) and also
causes pulmonary infections in older individuals. These species are
the common cause of the opportunistic mycobacterial disease
associated with AIDS, which occurs in 30–50% of patients with AIDS
in the United States and Europe, and lead to the diffused or miliary
tuberculosis (Gardner et al., 2011). Almost all cases related to AIDS
are due to strains which are genetically related to M. avium. In most
cases, the infection is widely disseminated in the body. In these
patients, the organism can be isolated from the blood, bone marrow
and stool. M. avium can survive in the soil for up to 4 years, although
sensitive to sunlight and ultraviolet radiation.
On the other hand, paratuberculosis (Jones disease) has spread
almost worldwide, especially in developing countries, as an endemic
disease and a major problem in many livestock production systems,
zoo enclosed animals, and wildlife animals. The disease report was
only from 6 to 12 countries around the world by 1997, but there are
currently numerous reports of occurrence, epidemiology, potential
zoonotic condition, and biological origins (by molecular methods)
from all continents. Epidemiological studies have suggested that the
risk of infection in males, black race humans, near‐equator countries,
rural areas, and occupations associated with soil and fertilizer is
higher (Carvalho, Pietralonga, Schwarz, Faria, & Moreira, 2012).
The MAP can be controlled, but early detection and proper
diagnosis are pivotal to prevent its transmission among animals (Cho
et al., 2012). The jones disease causes death without estimation and
called a silent killer. Therefore, some critical points have been
considered in controlling studies in recent decades such as its
epidemiology, identifying sources of infection, and the process of the
disease spreading (Chiers et al., 2012; Davis & Park, 2018; Lara et al.,
2011; Yong et al., 2011), some of which have been implemented in
Sweden and some states of Australia due to the use of valid reporting
systems and severe control measures as the only areas free of the
Jones disease in the world.
Reports of MAP tracing in commercially available pasteurized
milk from some countries such as the United States (8.2%), England
(1.7%), Argentina (86.2%), and India (67%; Garcia & Shalloo, 2015)
highlighted the possibility of association of paratuberculosis and CD
with contaminated food. There is still no evidence of animal to human
transmission, however, control of the disease in livestock, as the key
to the reduction of CD in humans is essential (Li, Katani, Schilling, &
Kapur, 2016).
The collected data on the epidemiology and ecology of livestock
in mild and temperate climates suggest that bovine paratuberculosis
infection is rare in tropical and subtropical areas. Therefore, the
infection may be due to the predominantly cows in temperate and
wet climates to the above areas. Studies have also shown that the
age‐specific factors such as pathogenicity of strain, severity, and
persistence of infection, sex, race, herd size, and stressors (labor,
malnutrition, transportation) in the development and evolution of the
disease and effective in clinical form. The most reliable method for
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detecting paratuberculosis‐infected animals is the culture of organ-
isms from various clinical specimens such as blood, milk, lymph
nodes, tissue (intestine, liver, testis, uterus, and bladder), and
especially fecal specimens.
Estimates of annual economic losses associated with ion disease
in the clinical and subclinical stage among dairy herds have shown
significant effects on national, regional and agricultural levels. The
largest economic impact of Jones disease is on livestock industry,
especially dairy cattle, where estimates of losses caused by reduced
immature slaughter, carcass weight loss, weight loss, reduced milk
production, and infertility in animals with high fecal excretion rates
are high in the United States alone ($250 million a year; Bates,
O’Brien, Liggett, & Griffin, 2018; Machado et al., 2018).
Over 100 years old, the prevalence of bovine paratuberculosis
has grown from 55% to 10% in the 1990s, based on the diversity of
the prevalence in the European countries (Li et al., 2016). The
prevalence rate of bacilli prevalence at herd and livestock levels
in European countries is 2–50% or higher. In Switzerland, this is
1.7–2.7%, Denmark 47%, Austria 19%, Belgium 18%, Ireland 9.5%,
Italy 14.14% 8.2%, and in France is estimated to be 6.2–6.6% (Dore
et al., 2012; Smith et al., 2016). In contrast, its rate in the United
States has been estimated at the herd level of 21–93% and at least
2.9% for each dairy cattle (McKenna, Keefe, Tiwari, VanLeeuwen, &
Barkema, 2006). National Animal Health Control System (NAHMS)
reports in the United States indicate that the prevalence of jones
disease has risen from 21% in 1996 to 93% in 2006, with 70% of
dairy herds and 10–5% of calves contaminated with the bacilli
(Ahlstrom et al., 2015; Gümüşsoy, Ica, Abay, Aydin, & Hizlisoy, 2015;
Slater et al., 2016b).
The first report of bovine paratuberculosis in African countries
dates back to 1923. According to the OIE database on animal health,
from 1980 until today, it appears that in most African countries, the
disease is endemic or sporadic, the prevalence of the disease in Egypt
has been reported 45.2% and 9%. The frequency of the disease is also
available in several Asian countries, such as Jordan 65%, India 25–25%
(Dirac et al., 2012), Korea 16.4%, Pakistan 76.6%, Turkey 4.3–7.2%,
and Cyprus 9/0%. The most important step in solving the para-
tuberculosis problem should be the implementation of surveillance
measures to control the disease and, if possible, to prevent contact
with predisposed and infected young animals. To prevent the spread of
infection, a close cooperation between farmers, livestock breeders,
and health inspectors is needed to protect animals susceptible to
irritable bowel syndrome by removing an infected animal with a test‐
slaughter solution and vaccination (Slater et al., 2016a).
In the area of protecting animals susceptible to MAP, effective
treatment of infections involves a variety of functions, including the
quarantination of newly born young calves in a separate site,
increasing the health level of calves, young animals feeding with
MAP‐free milk or supplements, control of contaminated water, and
food in separated animals, and the feeding of calves in fields free
from animal waste. Control programs in dairy cattle require the
slaughter of infected animals as the main health action to prevent
infection in young calves. Based on reports of control measures in
different countries, the test‐slaughtering strategy is based on the
results of three stool culture tests, ELISA, and eventually molecular
techniques that can be monitored, regardless of its economic
constraints, for administering in small herds, more than a total of
7 years for complete elimination of the disease.
In spite of extensive control efforts in different countries,
paratuberculosis remains an insoluble problem for the scientific
community of veterinary medicine, as they have not yet come up with
a single opinion to reach a more proper strategy to deal with this
disease, which is to some extent extended to the incubation period,
the lack of adequate knowledge for the precise differentiation of
strains, the limited knowledge regarding bacterial pathogens, and the
inadequacy of present vaccines. Studies have shown that killed and
subjunctive vaccines are effective in preventing the establishment of
a stable infection and limiting the progression of the disease, but they
have not been completely successful in infection prevention.
6 | THE M. AVIUM TRANSMISSION
The contaminated environment, especially the soil and infected bed, is
the most important source of transmission of infection to noninfected
animals (Bauman et al., 2017). The most important route of infection
transmission in birds is through food and contaminated water (oral–
fecal transmission). After ingestion, the microorganism disseminates
throughout the bird’s body and subsequently can be spread by feces
after propagation. If the bacterium is inhaled, lung injuries may
develop and skin invasion may also appear. Although MAC spread
through contaminated eggs may occur, this is not a common route in
the chickens hatching from the eggs (Bauman et al., 2017). The
development and spread of the bird’s tuberculosis do not occur by
industrial poultry through birds carcasses used to produce meat
powder. Cannibalism may also be involved in the transmission of the
disease. Detection of tuberculosis in birds is difficult due to the various
and uncertain signs, the length of the latency, the lack of appropriate
serological tests, and the difficulty in the agent’s culture in vitro
(Ahlstrom et al., 2016). MAC in birds has been limited to a small
number of studies worldwide. Therefore, the frequency and informa-
tion about of MAC infection among birds are uncertain.
7 | MOLECULAR TRACKING OF DISEASE
The transmission and epidemiology of MAP and MAC have been
investigated by several molecular methods. However, the application of
combined typing methods has been highlighted to achieve more accurate
results. Pulsed‐field gel electrophoresis has been used to this aim,
but the technique is time‐consuming and laborious. Multivariate tandem
repeat analysis, IS900 restriction fragment length polymorphism
(IS900RFLP) analysis and mycobacterial interspersed repetitive
unit–variable‐number tandem‐repeat typing have also demonstrated
proper results in the tracking of disease transmission and identification
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of zoonotic subspecies (Garvey, 2018; Kennedy & Benedictus, 2001;
Mikkelsen, Jungersen, & Nielsen, 2009).
8 | CONTROL AND PREVENTION
STRATEGIES
Control strategies for prevention of the infection can be mostly
classified as (a) discard or cleansing old or dirty equipment, (b) avoid
moving and migration of birds to suspected and infected places
and import of suspected herds, (c) removing old flocks and burning
carcasses, (d) buying new birds from specific and nonpolluted places,
(e) reducing the stress of birds as an important factor in increasing
bacterial excretion and disease evolution by reducing the density of
birds and providing adequate ventilation and the use of vitamin and
mineral supplements, (f) repeated disinfection of the birds and
livestock holding places, (g) monitoring the birds and livestock in the
field by testing tuberculin and agglutination, (h) quarantine new birds
for at least two months and conduct tuberculin testing, (i) even if
there is an infected bird, all herds should be removed, and
disinfection and removal of all equipment and even the Fulton herd
must be fulfilled and (j) vaccination of birds and herd (Abdellrazeq
et al., 2018; Cohn, 1997). However, the herd and livestock status and
national conditions are critical determinants of control plans.
9 | VACCINATION
There are no commercial vaccines for use against MAP andMAC. Several
live and killed experimental vaccines have been evaluated to protect
poultry against the disease. The most protective vaccine was evaluated
with M. intracellulare serovar 6 after oral use with 70% protection after
muscular injection with M. avium. In addition, recombinant vaccines and
subunits have been experimentally tested. Vaccination reduces the
number of injuries and bacilli but does not prevent the infection.
Induction of CD8+ and CD4+ responses are critical for the eradication of
intracellular infection, though limited cell apoptosis has been exhibited for
intracellular bacteria (Hermon‐Taylor et al., 2000a; Velaz‐Faircloth, Cobb,
Horstman, Henry, & Frothingham, 1999).
10 | CONCLUSION
The rate of MAP and MAC has remained high in most areas of the
world. Both agents cause zoonotic infections with a wide range of
hosts. In addition, related subspecies of MAC have been isolated
from clinical origins and environment. As zoonotic diseases, the risk
of development of occupational diseases and even death outcome
necessitate implementation of control strategies to prevent their
spread. Molecular epidemiological studies are useful to track specific
sources. Other subspecies of MAC based on 16s rRNA sequencing
mostly include M. chimaera (or MAC‐A serovar from human
respiratory system), M. colombiense (from children lymph nodes),
M. arosiense (or MAC‐X serovar from systemic osteomyelitis of HIV‐
infected children), M. indicus pranii (MIP or Mw), M, vulneris (isolated
from ulcers), M. xenopi, and M. lepraemurium which caused infections
less common in humans.
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